30 May 2019
International team advises Chiesi Farmaceutici on in-licence of Raxone® from Santhera
www.twobirds.com/en/news/press-releases/2019/uk/international-team-advises-chiesi-farmaceutici-on-inlicence-of-raxone-from-santhera

International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")

18 April 2019
Bird & Bird Germany advises Aphria on its tender for the cultivation, processing and delivery of cannabis for medical purposes
www.twobirds.com/en/news/press-releases/2019/germany/bird-bird-beraet-aphria-im-vergabeverfahren-cannabis

We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes.